Menu

Oura and Dexcom to combine glucose sensing and wearable health tracking

Glucose monitoring company Dexcom and health tracking wearables firm Oura have announced a strategic partnership that aims to provide an integrated metabolic health management solution for consumers. A leader in continuous glucose monitoring (CGM) technology, Dexcom also revealed it has made a $75 million investment into Oura, valuing the Finnish company at more than $5 billion.

By enabling two-way data flow between Dexcom’s glucose biosensors and Oura’s smart ring technology, the partners intend to enable a more holistic understanding of metabolic health. The unified platform aims to gain insights into the interplay between glucose levels and various health factors, including sleep, stress, heart health and activity. The integration is expected to launch its first app-based feature by mid-2025.

Scroll to Top